Full Year 2022 Results

FY 2022 Key Stats
€98.0m
EBITDA
5.7%
Organic GP Growth YoY
17.3%
ROCE
18.4c
Adjusted EPS

Group Highlights

€306.7m
2022 GP

Employees

Partnering with 7 of the top 10 pharma companies

and 7 of the top 10 medical device companies
